Groupe Bruxelles Lambert Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Groupe Bruxelles Lambert heeft een totaal eigen vermogen van €16.2B en een totale schuld van €7.6B, wat de schuld-eigenvermogensverhouding op 46.6% brengt. De totale activa en totale passiva bedragen respectievelijk €27.7B en €11.5B. De EBIT Groupe Bruxelles Lambert is €802.6M waardoor de rentedekking 2.9 is. Het heeft contanten en kortetermijnbeleggingen van €2.9B.

Belangrijke informatie

46.6%

Verhouding schuld/eigen vermogen

€7.57b

Schuld

Rente dekkingsratio	2.9x
Contant	€2.91b
Aandelen	€16.24b
Totaal verplichtingen	€11.51b
Totaal activa	€27.75b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

Nov 04

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Sep 30

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

Jun 08

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Dec 18

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €5.3B ) GBLB } overtreffen de korte termijn passiva ( €2.8B ).

Langlopende schulden: De kortetermijnactiva van GBLB ( €5.3B ) dekken de langetermijnschulden ( €8.7B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 28.7% ) GBLB wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van GBLB is de afgelopen 5 jaar gestegen van 23.6% naar 46.6%.

Schuldendekking: De schuld van GBLB wordt niet goed gedekt door de operationele kasstroom ( 11.2% ).

Rentedekking: De rentebetalingen van GBLB op haar schulden worden niet goed gedekt door EBIT ( 2.9 x dekking).

Groupe Bruxelles Lambert Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Third quarter 2024 earnings released: €1.61 loss per share (vs €0.35 profit in 3Q 2023)

Groupe Bruxelles Lambert SA to Report Nine Months, 2025 Results on Nov 06, 2025

Groupe Bruxelles Lambert SA to Report First Half, 2025 Results on Jul 31, 2025

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

PE Firms Reportedly to Circle German Vitamin Supplement Maker Orthomol

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Groupe Bruxelles Lambert SA to Report Fiscal Year 2024 Results on Mar 13, 2025

Second quarter 2024 earnings released: EPS: €0.67 (vs €1.53 in 2Q 2023)

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: €1.43 (vs €0.74 in 1Q 2023)

Upcoming dividend of €1.93 per share

New major risk - Revenue and earnings growth

Groupe Bruxelles Lambert SA to Report Q3, 2024 Results on Nov 07, 2024

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Groupe Bruxelles Lambert SA to Report Q2, 2024 Results on Jul 31, 2024

Concentrix Corporation (NasdaqGS:CNXC) completed the acquisition of Webhelp SAS from Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Marnix Luxembourg S.à R.l. and management of Webhelp.

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Upcoming dividend of €1.93 per share at 3.5% yield

Full year 2022 earnings released

Price target decreased to €97.00

Third quarter 2022 earnings released

Second quarter 2022 earnings released: €1.38 loss per share (vs €0.72 profit in 2Q 2021)

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of €1.93 per share

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) signed an agreement to acquire an unknown majority stake in Sanoptis AG from Telemos Capital Limited.

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) along with the management of Affidea has signed a definitive agreement to acquire a majority stake in Affidea B.V. from B-FLEXION Group for approximately €1 billion.

Gbl Reportedly Set to Buy Affidea

Full year 2021 earnings: EPS and revenues miss analyst expectations

Groupe Bruxelles Lambert Reportedly Considering A Bid to Take Ontex Group Private

Third quarter 2021 earnings released: €0.29 loss per share (vs €0.40 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.72 (vs €2.49 in 2Q 2020)

Here's Why We Think Groupe Bruxelles Lambert (EBR:GBLB) Is Well Worth Watching

Upcoming dividend of €1.75 per share

Consensus forecasts updated

Full year 2020 earnings released: EPS €2.53 (vs €4.49 in FY 2019)

Price target increased to €95.11

Did You Miss Groupe Bruxelles Lambert's (EBR:GBLB) 44% Share Price Gain?

New 90-day high: €86.02

Is Groupe Bruxelles Lambert SA (EBR:GBLB) A Risky Dividend Stock?

How Much Of Groupe Bruxelles Lambert SA (EBR:GBLB) Do Institutions Own?

Groupe Bruxelles Lambert SA, Annual General Meeting, Apr 27, 2021

New 90-day high: €83.74

New 90-day high: €83.00

Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Future Shape LLC and Roman Arnold signed a definitive agreement to acquire Canyon Bicycles GmbH from TSG Consumer Partners, LP, Roman Arnold and others.

A Look At Groupe Bruxelles Lambert's (EBR:GBLB) CEO Remuneration

Analysts lower EPS estimates to €2.69

Third quarter 2020 earnings released: €0.40 loss per share

New 90-day low: €73.26

New 90-day high - €79.90

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) completed the acquisition of 60% stake in Webhelp SAS from KKR & Co. Inc. (NYSE:KKR), Frédéric Jousset, Olivier Duha and others.

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven